Twice-weekly pegylated interferon-α-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy

Twice-weekly pegylated interferon-α-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy

Item
http://www.wikidata.org/entity/Q33924165
Simeprevir with pegylated interferon alfa 2a plus ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a meta-analysis and historical comparisonA hepatitis C virus infection model with time-varying drug effectiveness: solution and analysisShort communication: serum-based assay accurately detects single nucleotide polymorphisms of IL28B and SOCS3 in HIV/hepatitis C virus-coinfected subjects.Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment.Interferon combination therapy for HIV/hepatitis C virus coinfection.Comparative efficacy, pharmacokinetic, pharmacodynamic activity, and interferon stimulated gene expression of different interferon formulations in HIV/HCV genotype-1 infected patients.Oxidized Low-Density Lipoprotein Is a Novel Predictor of Interferon Responsiveness in Chronic Hepatitis C InfectionPersistently elevated abnormal B-cell subpopulations and anti-core antibodies in patients co-infected with HIV/HCV who relapse.Impact of the peginterferon-α 2a and ribavirin plasma levels on viral kinetics and sustained virological response in genotype 1 HCV/HIV-co-infected patients with the unfavourable non-CC IL28B genotypes.Impact of ribavirin priming on viral kinetics and treatment response in chronic hepatitis C genotype 1 infection.Early viral kinetics: a novel guide for optimal dosing frequency of pegylated interferon-α-2a in HIV/HCV-coinfected patients.
P2860

Twice-weekly pegylated interferon-α-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy

Item
http://www.wikidata.org/entity/Q33924165
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Twice-weekly pegylated interfe ...... s compared to standard therapy
@ast
Twice-weekly pegylated interfe ...... s compared to standard therapy
@en
type
label
Twice-weekly pegylated interfe ...... s compared to standard therapy
@ast
Twice-weekly pegylated interfe ...... s compared to standard therapy
@en
prefLabel
Twice-weekly pegylated interfe ...... s compared to standard therapy
@ast
Twice-weekly pegylated interfe ...... s compared to standard therapy
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Twice-weekly pegylated interfe ...... s compared to standard therapy
@en
P2093
P2860
P304
P31
P356
10.1097/QAD.0B013E3283471D53
P407
P433
P478
P50
P577
P5875
P698
P932